Abbott Laboratories
(NYSE) ABT
Abbott Laboratories Financials at a Glance
Market Cap
$161.48B
Revenue (TTM)
$45.13B
Net Income (TTM)
$6.28B
EPS (TTM)
$3.59
P/E Ratio
25.83
Dividend
$2.44
Beta (Volatility)
0.53 (Low)
Dividend
$2.44
Beta (Volatility)
0.53 (Low)
Price
$90.66
Volume
9,936,931
Open
$93.29
Price
$90.66
Volume
9,936,931
Open
$93.29
Previous Close
$90.74
Daily Range
$90.61 - $93.29
52-Week Range
$81.97 - $137.49
Estimated Earnings Date
Jul 16, 2026
Dividend
$2.44
Beta (Volatility)
0.53 (Low)
Price
$90.66
Volume
9,936,931
Open
$93.29
Previous Close
$90.74
Daily Range
$90.61 - $93.29
52-Week Range
$81.97 - $137.49
Estimated Earnings Date
Jul 16, 2026
ABT News
ABT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Abbott Laboratories
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
115,000
CEO
Robert B. Ford, MBA
Website
www.abbott.comHeadquarters
Abbott Park, IL 60064-6400, US
ABT Financials
Key Financial Metrics (TTM)
Gross Margin
56.38%
Operating Margin
18.17%
Net Income Margin
13.91%
Return on Equity
12.20%
Return on Capital
11.98%
Return on Assets
5.68%
Earnings Yield
3.87%
Dividend Yield
2.63%
Payout Ratio
66.73%
Stock Overview
Market Cap
$161.48B
Shares Outstanding
1.74B
Volume
9.94M
Avg. Volume
13.04M
Financials (TTM)
Gross Profit
$25.45B
Operating Income
$8.20B
EBITDA
$11.21B
Operating Cash Flow
$9.46B
Capital Expenditure
-$2.09B
Free Cash Flow
$7.38B
Cash & ST Invst.
$7.30B
Total Debt
$34.05B
Abbott Laboratories Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$11.16B
+7.8%
Gross Profit
$6.28B
+15.4%
Gross Margin
56.28%
N/A
Market Cap
$161.48B
N/A
Market Cap/Employee
$1.42M
N/A
Employees
114,000
N/A
Net Income
$1.08B
-18.7%
EBITDA
$2.25B
-15.8%
Quarterly Fundamentals
Total Cash
$7.30B
+6.6%
Total Debt
$34.05B
+157.1%
Accounts Receivable
$8.21B
+12.1%
Inventory
$6.99B
+5.3%
Long Term Debt
$29.64B
+132.7%
Short Term Debt
$4.41B
+771.3%
Return on Assets
5.68%
N/A
Return on Invested Capital
8.91%
N/A
Free Cash Flow
$916.00M
-1.8%
Operating Cash Flow
$1.32B
-7.2%